Sign in

CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company

CURIS INC

Sign in to watch
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043505116
Phone
617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. CT ORDER Other Confidential Order
  2. CT ORDER Other Confidential Order
  3. 10-K Report Annual Report
  4. 8-K Event Results of operations
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 4 Grant or award Director acquired 185,000 shares (grant or award)
  8. 4 Grant or award Director acquired 185,000 shares (grant or award)
  9. 4 Grant or award Director acquired 185,000 shares (grant or award)
  10. 4 Grant or award Director acquired 185,000 shares (grant or award)
  11. 4 Grant or award Director acquired 185,000 shares (grant or award)
  12. 4 Grant or award Chief Medical Officer acquired 133,750 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 206,250 shares (grant or award)
  14. 4 Grant or award President & CEO acquired 206,250 shares (grant or award)
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 8-K Event Delisting notice
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 4 Open-market buy Director bought 25,000 shares at $0.98 ($24,500)
  19. 4 Open-market buy President & CEO bought 50,000 shares at $1.06 ($53,000)
  20. 8-K Event Regulation FD disclosure

Page 20 of 61 · 1,213 filings